John Harrison

11PUBLICATIONS
50CO-AUTHORS
GlycoconjugatesCognitionAutonomic nervous systemArt theoryMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 01, 2025
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial.

Paul Edison, Grazia Daniela Femminella, Craig Ritchie

|May 27, 2025
Smartphone- and Tablet-Based Tools to Assess Cognition in Individuals With Preclinical Alzheimer Disease and Mild Cognitive Impairment: Scoping Review.

Rosanne L van den Berg, Sophie M van der Landen, Matthijs J Keijzer

|Jan 02, 2024
Cognitive and Functional Change Over Time in Cognitively Healthy Individuals According to Alzheimer Disease Biomarker-Defined Subgroups.

Mark A Dubbelman, Heleen M A Hendriksen, John E Harrison

|Apr 28, 2023
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease.

Petr Novak, Branislav Kovacech, Stanislav Katina

|Sep 21, 2022
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration.

Ying Jiang, John J Alam, Stephen N Gomperts

|Jun 24, 2022
Further validation of the THINC-it tool and extension of the normative data set in a study of n = 10.019 typical controls.

Maria Dalby, Peter Annas, John E Harrison

Pageof 2

Frequent Collaborators

2 joint publications

Sietske Am Sikkes

2 joint publications

Wiesje M Van Der Flier

1 joint publications

Jennifer Rae Myers

1 joint publications

Jordan M Glenn